KCNQ1 and deafness: Variants linked to JLNS (homozygous or compound heterozygous KCNQ1 variants linked to QT prolongation and deafness) in the literature clustered within the loss-of-function range, with 83% (34/41) showing partial loss or loss-of-function in the MAVE assay (Figure 6E).